Clinical Obstetrics and Gynecology 1998: Vol 41 Index

31 Pages·1998·6.2 MB·English

Cumulative
Index
Volume 41, Numbers 1—4, 1998
Abdominal colposacropexy, 786 Agency for Health Care Policy and Research (AHCPR)
Abdominal myofascial pain, 422 Computerized Needs-oriented Quality Measurement
\bdominal wall defects. See Ventral wall defects Evaluation System, 348
\bdominal wound infection, with trial of labor after guidelines for healthcare, 315, 343
cesarean delivery, 369 internet address of, 348
Abnormal uterine bleeding responsibilities of, 343
anovulation and, 928 Aging population, demographics of, 895
with cirrhosis, 928 Albuterol, for asthma, in pregnancy, 555
differential diagnosis of, 928 Alpha adrenergic agents
evaluation of patient with, 928 adverse effects and side effects of, 691
latrogenic causes of, 928 estrogen therapy in combination with, for urinary
luteal phase and, 928 incontinence, 691
with malignancy, 928 for urinary incontinence, 691, 702
with myomas, 928 Alpha adrenergic antagonists, for voiding dysfunctions,
in perimenopause, 921, 928, 976 69|
with pregnancy, 928 Alpha-fetoprotein level
with reproductive disorders, 928 amniotic fluid, 564
with thyroid disorders, 928 maternal serum
treatment of, 928 in multiple gestation, 564
Abortion, spontaneous, age-related increase in, 958 and risk of fetal abnormalities, 564
\bruptio placentae Alprazolam
ambulatory management of, 52 for premenstrual syndrome, possible effectiveness of,
definition of, 527 405
etiology Gi-02) for voiding dysfunctions, 691
527
grades of, Ambulatory obstetric management, 479, 481
hospitalization for, 527 managed care and, 481
with hypertension in pregnancy, 533 American Board of Obstetrics and Gynecology, Amer-
incidence of, 527 ican Board Certification, 307
outcomes with, 527 American College of Obstetricians and Gynecologists
perinatal morbidity and mortality with, 527 (ACOG)
with preterm premature rupture of membranes, 503 Educational Bulletin, 343
risk factors for, 527 obstetric clinical indicators, 348
signs and symptoms of, 527 perspective on practice guidelines, 343
ultrasound findings with, ‘ position on electronic fetal monitoring, 362
vaginal bleeding with, 5
position on obstetric ultrasound, 67
Abuse, history of, and chronic pelvic pain, 422 Practice Bulletin, 343
Acardiac twinning, 564 Practice Patterns, 343
Acetylcholinesterase level, in amniotic fluid, 564
quality of care measures, 348
Activated protein C resistance, anticoagulation for, 545
American Medical Association (AMA), perspective on
Acupressure, for hyperemesis gravidarum, 597
practice guidelines, 343
Acute intermittent porphyria, chronic pelvic pain with,
Aminoglycosides, for pyelonephritis, 515
422
Amitriptyline (Elavil)
Acute pain. Se3e Pain, acute for chronic pelvic pain, 422
Adolescent, pregnant, hypertension in, management of,
for urinary incontinence, 691
3
Adult respiratory distress syndrome, with pyelonephritis Amniocentesis
in diagnosis of intra-amniotic infection, 503
in pregnancy, 515
therapeutic, for twin-twin transfusion syndrome, 37
105
Amnion, structure of, 810
Page numbers listed are those on which relevant article Amniotic fluid
begins acetylcholinesterase level in, 564
CLINICAL OBSTETRICS AND GYNECOLOGY VOLUME 41 NUMBER 4 DECEMBER 1998
990
Cumulative
Index
Volume 41, Numbers 1—4, 1998
Abdominal colposacropexy, 786 Agency for Health Care Policy and Research (AHCPR)
Abdominal myofascial pain, 422 Computerized Needs-oriented Quality Measurement
\bdominal wall defects. See Ventral wall defects Evaluation System, 348
\bdominal wound infection, with trial of labor after guidelines for healthcare, 315, 343
cesarean delivery, 369 internet address of, 348
Abnormal uterine bleeding responsibilities of, 343
anovulation and, 928 Aging population, demographics of, 895
with cirrhosis, 928 Albuterol, for asthma, in pregnancy, 555
differential diagnosis of, 928 Alpha adrenergic agents
evaluation of patient with, 928 adverse effects and side effects of, 691
latrogenic causes of, 928 estrogen therapy in combination with, for urinary
luteal phase and, 928 incontinence, 691
with malignancy, 928 for urinary incontinence, 691, 702
with myomas, 928 Alpha adrenergic antagonists, for voiding dysfunctions,
in perimenopause, 921, 928, 976 69|
with pregnancy, 928 Alpha-fetoprotein level
with reproductive disorders, 928 amniotic fluid, 564
with thyroid disorders, 928 maternal serum
treatment of, 928 in multiple gestation, 564
Abortion, spontaneous, age-related increase in, 958 and risk of fetal abnormalities, 564
\bruptio placentae Alprazolam
ambulatory management of, 52 for premenstrual syndrome, possible effectiveness of,
definition of, 527 405
etiology Gi-02) for voiding dysfunctions, 691
527
grades of, Ambulatory obstetric management, 479, 481
hospitalization for, 527 managed care and, 481
with hypertension in pregnancy, 533 American Board of Obstetrics and Gynecology, Amer-
incidence of, 527 ican Board Certification, 307
outcomes with, 527 American College of Obstetricians and Gynecologists
perinatal morbidity and mortality with, 527 (ACOG)
with preterm premature rupture of membranes, 503 Educational Bulletin, 343
risk factors for, 527 obstetric clinical indicators, 348
signs and symptoms of, 527 perspective on practice guidelines, 343
ultrasound findings with, ‘ position on electronic fetal monitoring, 362
vaginal bleeding with, 5
position on obstetric ultrasound, 67
Abuse, history of, and chronic pelvic pain, 422 Practice Bulletin, 343
Acardiac twinning, 564 Practice Patterns, 343
Acetylcholinesterase level, in amniotic fluid, 564
quality of care measures, 348
Activated protein C resistance, anticoagulation for, 545
American Medical Association (AMA), perspective on
Acupressure, for hyperemesis gravidarum, 597
practice guidelines, 343
Acute intermittent porphyria, chronic pelvic pain with,
Aminoglycosides, for pyelonephritis, 515
422
Amitriptyline (Elavil)
Acute pain. Se3e Pain, acute for chronic pelvic pain, 422
Adolescent, pregnant, hypertension in, management of,
for urinary incontinence, 691
3
Adult respiratory distress syndrome, with pyelonephritis Amniocentesis
in diagnosis of intra-amniotic infection, 503
in pregnancy, 515
therapeutic, for twin-twin transfusion syndrome, 37
105
Amnion, structure of, 810
Page numbers listed are those on which relevant article Amniotic fluid
begins acetylcholinesterase level in, 564
CLINICAL OBSTETRICS AND GYNECOLOGY VOLUME 41 NUMBER 4 DECEMBER 1998
990
Index 99]
alpha-fetoprotein level in, 564 for chronic pelvic pain, 422
assessment for preterm premature rupture of membranes, 461,
with preterm premature rupture of membranes, 832, 503, 832, 864, 870
849. 870 and gestational age-dependent morbidity, 461, 827
in diagnosis of intrauterine infection, 849 maternal outcome with, 461, 827
with prolonged premature rupture of membranes, NICHD-MFMU multicenter trial of, 461, 870
817 and perinatal infectious morbidity, 461, 827
automated WBC count, in diagnosis of intrauterine and perinatal mortality, 461, 827, 870
infection with PPROM, 849 pregnancy prolongation with, 461, 870
catalase, and intrauterine infection with PPROM, 849 prospective trials of, 461, 864, 870
cytokines, and intrauterine infection with PPROM, rationale for, 864
849 recommendations for, 864
ferning, with rupture of membranes, 503 regimen for, 461
glucose concentration, in diagnosis of intrauterine in- for pyelonephritis,
fection with PPROM, 849 intramuscular, 5
Gram stain, in diagnosis of intrauterine infection with intravenous, 5
PPROM, 849 oral, 515
interleukin-1B, and intrauterine infection with in pregnancy, 744
PPROM, 849 for urinary tract infections, 744
interleukin-6, and intrauterine infection with PPROM, Anticholinergic agents
849 adverse effects and side effects of, 691
leukocyte esterase, and intrauterine infection with antispasmodic, for urinary incontinence, 691
PPROM, 849 for urinary incontinence, 691
nitrazine test for, with rupture of membranes, 503 Anticoagulation, 545
pooling in posterior vaginal fornix, with rupture of for activated protein C resistance, 545
membranes, 503 agents for, 545
testing, in diagnosis of intra-amniotic infection, 503 for antiphospholipid antibody syndrome, 545
volume, and intrauterine infection with PPROM, 849 for antithrombin deficiency, 545
Amniotic fluid index for coagulation disorders associated with thrombosis,
frequency of determinations of, 647 545
as marker of placental function, 647 indications for, in pregnancy and puerperium, 545
Amoxicillin, for preterm premature rupture of mem- outpatient management of, 545
branes, dosage and administration of, 461 prophylactic, 545
Ampicillin for protein C deficiency, 545
with gentamicin and clindamycin, for preterm prema- for protein S deficiency, 545
ture rupture of membranes, 864 therapeutic
for preterm premature rupture of membranes, 461, dosage and administration of, 545
864, 870 intrapartum management and, 545
for pyelonephritis. 515 for venous thromboembolism, 545
Ampicillin-sulbactam, for preterm premature rupture of Anti-D antibodies (Rhogam), for idiopathic thrombocy-
membranes, 864 topenic purpura in pregnancy, 436
Analgesics, oral, for chronic pelvic pain, 422 Antiemetics
Anemia for hyperemesis gravidarum, 597
in multiple gestation, 564 for nausea and vomiting in pregnancy, 597
with twin gestation, 85 Antihistamines, for asthma, in pregnancy, 555
Anencephaly, 393 Antihypertensive therapy
Aneuploidy effects on urinary incontinence, 663
fetal, in multiple gestation in pregnancy, studies of, 533
detection of, 564 Anti-inflammatory agents, for asthma, in pregnancy, 555
risk of, 564 Antiphospholipid antibody syndrome, anticoagulation
maternal age-related increase in, 958 for, 545
Angiotensin-converting enzyme inhibitors, Antithrombin, deficiency, anticoagulation for, 545
nancy, adverse effects of, 533 Anxiety, maternal
Antenatal testing. See also Fetal assessment during antepartum care in high-risk pregnancy, 626
in ambulatory setting, 481 postpartum, early postpartum discharge and, 611
costs of, 481 Anxiolytics, for premenstrual syndrome, possible effec-
variation in, by geographic region, 481 tiveness of, 405
Antepartum testing. See also Fetal assessment ARDS. See Adult respiratory distress syndrome
Doppler velocimetry in, 647 ART. See Assisted reproductive technology
frequency of, 647 Aspirin, for anticoagulation, in pregnancy, 54
historical perspective on, 647 Assisted reproductive technology (ART)
indications for, 647 monozygotic twinning with, 127
initiation of, 647 multifetal gestation and, 47, 57, 127, 564
Antibiotic therapy in older women, 940
for chorioamnionitis, 503 success rates, in older women, 940
992 INDEX
signs and s\
Baden defect <
Bayes’ theorem, 2
Beck Depression Inventory
Beclomethasone, fot
Bed rest
in high-risk pregnancy
adherence to, 62
ymnpntt oms ol sss
S perspective on, { 626
mild ‘rsus hospital,1 626
definition of information about, 626
nanagen prescription of, practices in, 481
moderate recommendations for research on, 626
dleeffiinniittiiono n of of, resource books on, 626
rs related to, 626
support groups and networks for, 626
in mull tiple gestation, 564
for placenta previa, 527
for preterm labor and threatened preterm delivery,
49]
for SS45 with preterm premature rupture of membranes, 870
if S54 and |p revention of f preterm delivery In twin gestation,
13
matermmal assessment with, 355
maternal complications of, 555 Behavior therapy, for urinary incontinence, 702
morbidity and mortality with, 555 Bendectin, for hyperemesis gravidarum, 597
outcomes with, 555 Bentyl. See Dicyclomine hydrochloride
pharmacologic therapy for, 555 Benzodiazepines, for voiding dysfunctions, 691
rapid progression Of, risk Tactors for, 355 Beta-blockers, in pregnancy, 533
ee ery in twin gestation,
severe Bethanechol chloride, for urinary incontinence
definition of, 555 adverse effects and side effects of, 691
gement during pregnancy, 555 dosage and administration of, 691
mechanism of action, 691
in outpatient management during preg- precautions with, 691
nancy, 555 Bias. See also Recall bias
Asymptomatic | empirical evidence of, 245
in children, in historical comparisons, 245
in chronic nonrandomized comparisons and, 2+ 45
definition of in observational studies, “3J2J5
in diabetes mellitus, 7 prevention of
in el1d4 erly women, in randomized controlled trials, 245
epidemiology of, 744 study design and, 307
in full-term infants, 744 in randomized controlled trials, prevention of, 245
1 pregnancy, 744 Biofeedback, for pelvic floor muscle strengthening, 7
management, incremental cost-effectiveness of, Biophysical profile
296 advantages and disadvantages of, 647
prevalence of, 744 in diagnosis of intra-amniotic infection, 503
progression to clinical urinary tract infection, 744 frequency of, 647
and pyelonephritis, 51 and intrauterine infection with PPROM, 849,
Ataxia, assessment for, in patient with urinary inconti- modified, 647
nence, 663 frequency of, 647
Ataxia telangiectasia, 172 in multiple gestation, 564
Ativan. See Lorazepam principles and rationale for, 647
Atropine, for urinary incontinence, 691 Birth certificates, data from, 3
Birth defects, prenatally diagnosed
Baclofen, for voiding dysfunctions, 691 management options for, 393
Bacteremia, and pyelonephritis, 515, 744 prophylactic cesarean delivery for, 393
Bacterial vaginosis, and preterm delivery, 810 Birth weight
Bacteriuria. See also Asymptomatic bacteriuria discordancy, and neonatal mortality with multiple
after cystourethroscopy, 764 gestation, 57
in pregnancy, 744 of multiples, characterization, 57
BRCA]I
direct
founder mutator
mutations, 14
il imp
population screening
Breast cancer
familial, 157
epidemiolog
prophylactic surgery and1,
risk assessment, genetic testi
risk reduction, 200
history of, estrogen replacement therayi py and, 966 ausation

996 INDEX
parison
comparison of, 6
n urodynamic testing, 672
treatment of,
Cystaorsicaoblpeys in, 672 Dehydration, neonatal, and ystpartum discharge,
611
Delivery
55 cesarean. See Cesarean delivery
Cystourethroscopy, indications for, with mild maternal hypertension, 533
bacteriuria after, 764 instrument use in, effects of epidural analgesia on,
bladder pathology seen on, 764 449
t oJ
on cystometry, 6
definition of, 691
e diagnosis of
‘ter dyssyne
nellitus
ymptoma -riuria
classification of, 584 cost-effectiveness
stational. See Gestational diabetes definition of.
insulin-dependent (type 1)
follow-up, for
eclpiindiceamli olcohagrya cteofr,i st5i8c4s of SRA + MnISstut Orreirca-lm a| npdeartspeed‘ c,t i\ 61
noninsulin-dependent (type 2)
clinical characteristics of, 584
epidemiology of, 584
preconception care and, 584
in pregnancy. See also Gestational diabetes
998 INDEX
maternal and newborn outcomes with, 61 1 for anticoagulation therapy, 545
maternal issues after, 611 dosage and administration of, in pregnancy, 545
newborn after nteral nutrition, in hyperemesis gravidarum, 597
follow-up examination of, 61] nterocele
genetic screening tests for, 611 identification of, 663
hyperbilirubinemia in, 611 intraoperative, in hysterectomy, 786
problems of, 611 and rectocele, differentiation of, 663
rehospitalization rates for, 611 surgical management of, 786
nurses’ in-home visits a fter, 611 nzymes, collagenolytic
Eclampsia, definition of, Ss 2 bacterial, and premature rupture of membranes, 810
cologic studies, 2 23 s and premature rupture of membranes, 810
design of, 235 phedrine
use of, 235 in management of urinary incontinence, 702
ctopic pregnancy, medical management of, for urinary incontinence, 691
laparoscopic salpingostomy in, 382 pidermal growth factor, and age-related ovarian
local methotrexate in, 382 changes, 898
methods of, 382 pidural analgesia, for labor
systemic methotrexate in, 382 advantages of, 449
dema, definition of, 533 effect on cesarean delivery rate, 449
ffective Care in Pregnancy and Childbirth (ECPC), 315 prospective trials of
ffective Newborn Care comparing two epidural techniques, 449
ffect size (6), 257 randomizing to epidural versus nonepidural, 449
lavil. See Amitriptyline hydrochloride retrospective studies of, 449
lectrical stimulation, for pelvic floor muscle strength- comparing epidural versus nonepidural groups,
ening, 702 449
lectrocardiography, fetal, 647 using historical control groups, 449
lectromyography, in urogynecology and intrapartum maternal fever, 449
indications for, 672 timing of epidural placement, and risk of cesarean
principles and rationale for, 672 delivery, 449
Electronic fetal monitoring (EFM) Epi-Info 6.0, 257
efficacy of, meta-analysis of, 275, 362 Epsilon-aminocaproic acid, for women with dysfunc-
U.S. Preventive Services Task Force recommenda- tional uterine bleeding, 928
tions on, 332 Erythrocyte sedimentation rate, in diagnosis of intrauter-
mepronium bromide, for urinary incontinence, 691 ine infection with PPROM, 849
mepronium carragenate, for urinary incontinence, 691 Erythromycin, for preterm premature rupture of mem-
ncephalocele, 393 branes, 461, 864, 870
ndocrine changes, in perimenopause, 913, 921, 976 Escherichia coli
ndometrial ablation, in treatment of dysfunctional uter- pyelonephritis caused by, 515, 744
ine bleeding, 928 urinary tract infection caused by, 744
ndometrial biopsy, in patient with abnormal uterine Estradiol
bleeding, 928 levels, age-related changes in, 913
ndometrial cancer ovulation suppression by, for premenstrual syndrome,
dysfunctional uterine bleeding with, 928 effectiveness of, 405
estrogen replacement therapy and, 966 for urinary incontinence, 691
estrogen status and, 167 Estriol
familial, 167 maternal salivary levels of, and risk of preterm deliv-
epidemiology, 200 ery, 49]
risk reduction, 200 for urinary incontinence, 691
genetics, studies of, 167 Estrogen replacement therapy
incidence, 167 contraindications to, 966
mortality, 167 and endometrial cancer, 966
population screening for, 200 and history of breast cancer, 966
p53 tumor suppressor gene and, 172 and hypertriglyceridemia, 966
risk factors for, 167, 200, 928 for perimenopausal woman, 976
Endometrial hyperplasia risk/benefit assessment for, 966
and carcinogenesis, 928 Estrogen therapy
dysfunctional uterine bleeding with, 928 benefits of, 691
perimenopausal, hormone replacement therapy and, in combination with alpha adrenergic agonists, for
966 urinary incontinence, 691
Endometriosis, chronic pelvic pain with, 422 effects on incidence of UTIs, 744
Endometritis, postpartum, with preterm premature rup- for urinary incontinence, 691, 702
ture of membranes, 503, 832 Evening primrose oil (EPO), for premenstrual syn-
Endoscopic laser surgery, for twin-twin transfusion syn- drome, ineffectiveness of, 405
drome, 37, 105 Evidence
Enoxaparin levels of, 307, 332